Insilico Medicine

Insilico Medicine and University of Toronto Partner to Develop AI Drugs for ‘Undruggable’ Cancer Targets

Featured News Report Technology

Insilico Medicine and University of Toronto Partner to Develop AI Drugs for ‘Undruggable’ Cancer Targets

by Kumar Gandharv

February 1, 2024

Insilico Medicine Advances AI-Designed IBD Drug ISM5411 to ‘First-in-Human’ Trial

Featured News Report Technology

Insilico Medicine Advances AI-Designed IBD Drug ISM5411 to ‘First-in-Human’ Trial

by Victor Dey

December 7, 2023

Hot Stories

Trezor Discloses ShipMonk Data Breach Affecting 13,700 Customers Across Seven Countries

by Alisa Davidson

August 13, 2026

Anthropic Meta-Analysis: Worker Retraining Delivers Modest Returns, Likely Insufficient For Mass AI Displacement

by Alisa Davidson

August 13, 2026

Venga Becomes B2B Infrastructure Provider, Leverages MiCA Authorization To Power Compliant Crypto Services In Europe

by Alisa Davidson

August 13, 2026

Gate Releases July 2026 Transparency Report: Excess Reserves Reinforce Asset Backing As Diversified Growth Consolidates Market Leadership

by Alisa Davidson

August 13, 2026

Latest News

Trezor Discloses ShipMonk Data Breach Affecting 13,700 Customers Across Seven Countries

by Alisa Davidson

August 13, 2026

Anthropic Meta-Analysis: Worker Retraining Delivers Modest Returns, Likely Insufficient For Mass AI Displacement

by Alisa Davidson

August 13, 2026

Venga Becomes B2B Infrastructure Provider, Leverages MiCA Authorization To Power Compliant Crypto Services In Europe

by Alisa Davidson

August 13, 2026

Gate Releases July 2026 Transparency Report: Excess Reserves Reinforce Asset Backing As Diversified Growth Consolidates Market Leadership

by Alisa Davidson

August 13, 2026